Drug Policy Alliance Logo
About Take Action News Publications and Library Blog Contact Donate Events Community eStore
Home > About > Staff & Board > Roseanne Scotti

About About

Reform Conf 2009

Marijuana: The Facts
What's Wrong With the Drug War?
Overdose
Safety First: Parents, Teens and Drugs
Drug By Drug
State By State
Reducing Harm: Treatment and Beyond
Drugs, Police & the Law
Communities Affected
Drug Policy Around the World
Publications and Library
What People are Talking About

Your Email
> Manage Subscriptions
What People are Talking About

Join the Drug Policy Alliance Network's work to promote drug policies based on science, compassion, health, and human rights.
Donate
> Get Involved
In this Section
bottom
The Latest

An Exit Strategy for the Drug War



Send A Message
Full Text Resources

> more

Suggested Web sites
> more links

  

Roseanne Scotti, Director, Drug Policy Alliance of New Jersey

Roseanne Scotti

Roseanne Scotti is director of Drug Policy Alliance New Jersey.  Before joining the organization, Scotti was a research coordinator at the University of Pennsylvania’s Center for Studies of Addiction in the HIV Prevention Research Division. As a research coordinator, she worked on various research projects studying the incidence of HIV among injection drug users with the goal of designing effective prevention interventions. Scotti received her B.A. from the University of Pennsylvania and her J.D. from Temple School of Law.

Scotti has authored and co-authored law review and medical journal articles on HIV prevention and drug policy. She founded the Prevention Point Philadelphia Harm Reduction Law Project, which provides free legal assistance for drug users and sex workers in Philadelphia. She lectures often on the issues of harm reduction and drug policy.

In 2004, Scotti received the award for Outstanding Achievement in the Field of HIV Prevention from the New Jersey HIV Prevention Community Planning Group. In 2005, she was appointed to New Jersey's Gang Land Security Task Force.



Provide Feedback on this Page:

* 1.




 2.



 3.



   Please leave this field empty